Cancer Drugs: Better, Cheaper

Options

Comments

  • jenrio
    jenrio Member Posts: 558
    edited July 2012

    Bump.  this article seems to see Ispy-2 mainly for early stagers.   Truth is any drugs accelerated through this trial process could benefit everyone, late stagers too.   

    We need other (non neoadjuvant) clinical trials that tests anti-metastasis and anti-stem-cell drugs too.   But neoadjuvant clinical trials are the way to go for cheaper drugs sooner.

Categories